Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
|Articles|April 2, 2019
- Pharmaceutical Technology-04-02-2019
- Volume 43
- Issue 4
High Shear Planetary Dispersers
The Ross PowerMix is a hybrid planetary mixer suited to address the need for high shear in formulations too viscous for conventional dual-shaft mixers.
The Ross PowerMix is a hybrid planetary mixer suited to address the need for high shear in formulations too viscous for conventional dual-shaft mixers. The mixer is equipped with the patented high-viscosity stirrer blade, providing axial product movement and radial exposure to a high-speed disperse blade, which in turn breaks down agglomerates and promotes rapid solids wet-out. Both the stirrer blade and saw-tooth disperser revolve around the batch while rotating on individual axes at independent speeds. The mixer is available across a range of working capacities including 1 quart to 1000 gallons.
Articles in this issue
over 7 years ago
Cleaning Chromatography Resin Residues from Surfacesover 7 years ago
OSD Continuous Manufacturing Strategiesover 7 years ago
Channeling Customer Complaints into Qualityover 7 years ago
Continuous Manufacturing Gains Major Push from FDAover 7 years ago
Particles on Best Behaviorover 7 years ago
Spray Drying: Supporting Patient-Centric Drug Developmentover 7 years ago
Advanced Cell Penetrating Peptide Systems for Gene Therapyover 7 years ago
Degradation Pathways: A Case Study with Pegylated L-Asparaginaseover 7 years ago
Locking Fraudulent Materials Out of the Supply ChainRelated to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
USP data show fewer US drug shortages but longer ones, averaging 5+ years. Drug shortages are an incentive problem, not a manufacturing mystery.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
France Remains One of Europe’s Leading Biotech Funding Hubs
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5